Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Hartmann

Showing results (41-50 of 114) with videos related to

Pageof 12
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 13, 1998
Phase I pharmacological study of intra-arterially infused fotemustine for colorectal liver metastasesJ T Hartmann, E Schmoll, C Bokemeyer, et al.
Investigational New Drugs|July 27, 2012
A phase I pharmacokinetic study of matuzumab in combination with paclitaxel in patients with EGFR-expressing advanced non-small cell lung cancerJ T Hartmann, C Kollmannsberger, I Cascorbi, et al.
Journal of Endocrinological Investigation|October 10, 2007
Symptomatic hypoglycemia during imatinib mesylate in a non-diabetic female patient with gastrointestinal stromal tumorM Haap, B Gallwitz, C Thamer, et al.
Anti-Cancer Drugs|April 11, 2000
The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumorsJ T Hartmann, S Knop, L M Fels, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 14, 2009
High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumorsA Lorch, A Neubauer, M Hackenthal, et al.
Investigational New Drugs|July 6, 2012
Pemetrexed in patients with refractory soft tissue sarcoma: a non-comparative multicenter phase II study of the German Sarcoma Group AIO-STS 005J T Hartmann, S Bauer, G Egerer, et al.
Seminars in Oncology|January 14, 1998
Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancerC Bokemeyer, J T Hartmann, C S Lampe, et al.
Investigational New Drugs|September 1, 2005
An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcomaJ T Hartmann, K Oechsle, J Huober, et al.
Anti-Cancer Drugs|July 11, 1998
Phase II study of continuous 120 h infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent colorectal cancerJ T Hartmann, A Harstrick, T Daikeler, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1996
Treatment of clinical stage I testicular cancer and a possible role for new biological prognostic parametersC Bokemeyer, M A Kuczyk, J Serth, et al.
Pageof 12

Showing results (41-50 of 114) with videos related to

Sort By:
Pageof 12
European Journal of Cancer (Oxford, England : 1990)|June 13, 1998
Phase I pharmacological study of intra-arterially infused fotemustine for colorectal liver metastasesJ T Hartmann, E Schmoll, C Bokemeyer, et al.
Investigational New Drugs|July 27, 2012
A phase I pharmacokinetic study of matuzumab in combination with paclitaxel in patients with EGFR-expressing advanced non-small cell lung cancerJ T Hartmann, C Kollmannsberger, I Cascorbi, et al.
Journal of Endocrinological Investigation|October 10, 2007
Symptomatic hypoglycemia during imatinib mesylate in a non-diabetic female patient with gastrointestinal stromal tumorM Haap, B Gallwitz, C Thamer, et al.
Anti-Cancer Drugs|April 11, 2000
The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumorsJ T Hartmann, S Knop, L M Fels, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 14, 2009
High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumorsA Lorch, A Neubauer, M Hackenthal, et al.
Investigational New Drugs|July 6, 2012
Pemetrexed in patients with refractory soft tissue sarcoma: a non-comparative multicenter phase II study of the German Sarcoma Group AIO-STS 005J T Hartmann, S Bauer, G Egerer, et al.
Seminars in Oncology|January 14, 1998
Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancerC Bokemeyer, J T Hartmann, C S Lampe, et al.
Investigational New Drugs|September 1, 2005
An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcomaJ T Hartmann, K Oechsle, J Huober, et al.
Anti-Cancer Drugs|July 11, 1998
Phase II study of continuous 120 h infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent colorectal cancerJ T Hartmann, A Harstrick, T Daikeler, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1996
Treatment of clinical stage I testicular cancer and a possible role for new biological prognostic parametersC Bokemeyer, M A Kuczyk, J Serth, et al.
Pageof 12